- Home
- MVST vs STXS Comparison
MVST vs STXS Comparison
Compare MVST & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVST
- STXS
- Stock Information
- Founded
- MVST 2006
- STXS 1990
- Country
- MVST United States
- STXS United States
- Employees
- MVST N/A
- STXS 139
- Industry
- MVST Industrial Machinery/Components
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MVST Miscellaneous
- STXS Health Care
- Exchange
- MVST Nasdaq
- STXS Nasdaq
- Market Cap
- MVST 848.0M
- STXS 254.1M
- IPO Year
- MVST N/A
- STXS 2004
- Fundamental
- Price
- MVST $3.42
- STXS $2.79
- Analyst Decision
- MVST Strong Buy
- STXS
- Analyst Count
- MVST 1
- STXS 0
- Target Price
- MVST $6.00
- STXS N/A
- AVG Volume (30 Days)
- MVST 4.9M
- STXS 343.7K
- Earning Date
- MVST 11-11-2025
- STXS 11-10-2025
- Dividend Yield
- MVST N/A
- STXS N/A
- EPS Growth
- MVST N/A
- STXS N/A
- EPS
- MVST N/A
- STXS N/A
- Revenue
- MVST $422,605,000.00
- STXS $31,806,000.00
- Revenue This Year
- MVST $24.21
- STXS $30.92
- Revenue Next Year
- MVST $31.67
- STXS $43.27
- P/E Ratio
- MVST N/A
- STXS N/A
- Revenue Growth
- MVST 20.84
- STXS 33.94
- 52 Week Low
- MVST $0.15
- STXS $1.54
- 52 Week High
- MVST $4.72
- STXS $3.05
- Technical
- Relative Strength Index (RSI)
- MVST 65.85
- STXS 50.84
- Support Level
- MVST $3.18
- STXS $2.73
- Resistance Level
- MVST $3.45
- STXS $2.94
- Average True Range (ATR)
- MVST 0.19
- STXS 0.09
- MACD
- MVST 0.10
- STXS -0.03
- Stochastic Oscillator
- MVST 91.04
- STXS 31.48
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.